Dasgupta D, Tripathi A, Griffard-Smith R, Yellapu N, et al. Therapeutic potential of NRF2 activating drug RTA-408 in suppressing T cell effector responses and inflammatory bowel disease. J Immunol 2025 Jun 16:vkaf117. doi: 10.1093.
PMID: 40570091